miR-29a/b1 Regulates BACE1 in Aluminum-Induced Aβ Deposition in Vitro.

Aluminum is an environmental neurotoxin that comes extensively in contact with human beings. Animal and human studies demonstrated that aluminum exposure increases the deposition of beta amyloid proteins in the brain as it was observed in Alzheimer's disease. The purpose of this study was to investigate whether miR-29a/b1 affected the expression of beta-secrete enzymes (BACE1) in the process of amyloid β-protein (Aβ) deposition caused by aluminum exposure. The study was performed using two different cell lines. Our results showed that after rat primary cortical neurons were exposed to aluminum, BACE1 gene and protein levels increased to different degrees, and the expression level of Aβ1-42 increased. In aluminum-exposed groups, the expression of miR-29a and miR-29b1 decreased, while the expression of amyloid protein Aβ1-42 and BACE1 increased. In miRs transfection groups, the expression of amyloid protein Aβ1-42 and BACE1 decreased. Aluminum may affect the expression of BACE1 by lowering miR-29a and miR-29b1. AEK293 cells were utilized in this research since they present elevated levels of miR-29a and miR-29b1. After HEK293 cells were exposed to aluminum alone, BACE1 mRNA and BACE1 protein expression levels increased with the increase of aluminum exposure dose (p < 0.05), and the level of Aβ1-42 also increased (p < 0.05). Compared with the group exposed to aluminum alone at the same doses, the expression levels of BACE1 mRNA and BACE1 protein in the miRs transfected plus aluminum-exposed groups significantly decreased (p < 0.05), and the level of Aβ1-42 also decreased (p < 0.05). This result is consistent with the investigation in rat primary neurons. The results of two types of cells showed that aluminum may cause abnormal down-regulation of the expressions of miR-29a and miR-29b1, thus negatively regulating the increase of BACE1 expression and finally leading to the increase of Aβ.

[1]  Jennifer D. Oduro,et al.  Aluminium in plasma and tissues after intramuscular injection of adjuvanted human vaccines in rats , 2019, Archives of Toxicology.

[2]  H. Ulrich,et al.  Aluminum affects neural phenotype determination of embryonic neural progenitor cells , 2019, Archives of Toxicology.

[3]  Yue-Yang Zhao,et al.  Effects of Aluminium on β-Amyloid (1–42) and Secretases (APP-Cleaving Enzymes) in Rat Brain , 2014, Neurochemical Research.

[4]  J. Padmanabhan,et al.  Altered Processing of Amyloid Precursor Protein in Cells Undergoing Apoptosis , 2013, PloS one.

[5]  Xiuling Zhi,et al.  Inhibitory effect of curcumin on the Al(III)-induced Aβ₄₂ aggregation and neurotoxicity in vitro. , 2012, Biochimica et biophysica acta.

[6]  D. Galimberti,et al.  Progress in Alzheimer’s disease , 2012, Journal of Neurology.

[7]  Yun Cui,et al.  MiR-29a Inhibits Cell Proliferation and Induces Cell Cycle Arrest through the Downregulation of p42.3 in Human Gastric Cancer , 2011, PloS one.

[8]  J. Zhang,et al.  Identification of Differentially-Expressed Proteins between Early Submucosal Non-Invasive and Invasive Colorectal Cancer Using 2D-DIGE and Mass Spectrometry , 2011, International journal of immunopathology and pharmacology.

[9]  R. Dabeka,et al.  Lead, cadmium and aluminum in Canadian infant formulae, oral electrolytes and glucose solutions , 2011, Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment.

[10]  S. Bronk,et al.  Transcriptional suppression of mir‐29b‐1/mir‐29a promoter by c‐Myc, hedgehog, and NF‐kappaB , 2010, Journal of cellular biochemistry.

[11]  V. D’Agata,et al.  Early effects of aluminum chloride on beta-secretase mRNA expression in a neuronal model of ß-amyloid toxicity , 2010, Cell Biology and Toxicology.

[12]  S. Kakimi,et al.  Demonstration of aluminum in amyloid fibers in the cores of senile plaques in the brains of patients with Alzheimer's disease. , 2009, Journal of Inorganic Biochemistry.

[13]  S. Pimplikar,et al.  Reassessing the amyloid cascade hypothesis of Alzheimer's disease. , 2009, The international journal of biochemistry & cell biology.

[14]  Bing Zhang,et al.  Altered expression of Aβ metabolism-associated molecules from d-galactose/AlCl3 induced mouse brain , 2009, Mechanisms of Ageing and Development.

[15]  E. Creppy,et al.  Bioaccumulation of water soluble aluminium chloride in the hippocampus after transdermal uptake in mice , 2009, Archives of Toxicology.

[16]  Xiaohu Tang,et al.  The art of microRNA: various strategies leading to gene silencing via an ancient pathway. , 2008, Biochimica et biophysica acta.

[17]  A. Delacourte,et al.  Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression , 2008, Proceedings of the National Academy of Sciences.

[18]  D. Hartmann,et al.  Part-Time α-Secretases: The Functional Biology of ADAM 9, 10 and 17 , 2008 .

[19]  G. Knapp,et al.  Occupational aluminum exposure: evidence in support of its neurobehavioral impact. , 2007, Neurotoxicology.

[20]  C. Morrison,et al.  MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B , 2007, Proceedings of the National Academy of Sciences.

[21]  A. Pasquinelli,et al.  MicroRNA silencing through RISC recruitment of eIF6 , 2007, Nature.

[22]  S. Kaech,et al.  Culturing hippocampal neurons , 2006, Nature Protocols.

[23]  G. Turgut,et al.  The effects of low dose aluminum on hemorheological and hematological parameters in rats , 2006, Archives of Toxicology.

[24]  Sang-Hyun Kim,et al.  Aluminum-maltolate induces apoptosis and necrosis in neuro-2a cells: potential role for p53 signaling. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[25]  C. Exley.  The aluminium-amyloid cascade hypothesis and Alzheimer's disease. , 2005, Sub-cellular biochemistry.

[26]  H. Tähti,et al.  Mitochondrial viability and apoptosis induced by aluminum, mercuric mercury and methylmercury in cell lines of neural origin , 2004, Archives of Toxicology.

[27]  H. Cai,et al.  Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer's disease patients , 2004 .

[28]  I. Skoog,et al.  Hypertension, hypertension-clustering factors and Alzheimer's disease , 2003, Neurological research.

[29]  P. McNamara,et al.  Aluminium toxicokinetics: an updated minireview. , 2001, Pharmacology & toxicology.

[30]  R. Nitsch,et al.  Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils , 2001, Science.

[31]  I. Kola,et al.  BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. , 2001, Human molecular genetics.

[32]  W. Richards,et al.  Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation , 2001, Nature Neuroscience.

[33]  S H Ferris,et al.  Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. , 1997, JAMA.

[34]  R. J. Williams,et al.  The natural selection of the chemical elements , 1997, Cellular and Molecular Life Sciences CMLS.

[35]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.